search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
LIMS & Lab Automation


Time to integrate: how advanced informatics enables automation, optimisation and compliance


Dr Cheryl Moody Bartel, Thermo Fisher Scientifi c


In the pharmaceutical industry, data is everything. Collecting and maintaining accurate, reliable data allows drug developers and manufacturers to ensure operations are robust and reliable, analyses are accurate, and products are of appropriately high quality. Intelligent data management is essential for organisations wanting to increase their productivity or create new opportunities for innovation - and, as the regulations overseeing a product’s journey to market become increasingly stringent, data quality and integrity are more important than ever.


To this end, advanced laboratory information management systems (LIMS) are playing an instrumental role in achieving the robust, integrated informatics essential for market success. Such systems enable workfl ows to become more automated, while also integrating and connecting data from multiple sources to drive fast, informed decision-making. Connectivity and integration are even more crucial for distributed laboratory networks, where they can bring operational effi ciency and productivity gains which, in turn, facilitate the faster delivery of new therapies to patients in need. Furthermore, connected, integrated information management is essential to maintain a safe, steady, reliable global supply chain - the value of which is evident especially in the current landscape, given the disruption and rapidly evolving healthcare needs associated with the COVID-19 pandemic.


The challenges of laboratory and data integration


Data is continuously generated and stored throughout the stages of research, development, clinical testing, commercialisation and manufacturing of drug products, making informatics a key consideration for the pharmaceutical industry. Everything from equipment operation, calibration and validation to the use of various reagents and standards must be logged and tracked - and for this, organisations rely upon well-managed records. However, traditional systems for information management are typically quite disparate and require extensive manual input. Many organisations use digital systems that are not integrated across different locations, instruments or datasets, making connectivity a real issue.


Meanwhile, pressure is increasing to accelerate pharmaceutical pipelines, and global regulations are growing more stringent and complex. To keep pace and remain competitive, drug developers and manufacturers are seeking verifi ably robust, integrated informatics systems - solutions that capture data and both monitor and manage operations by applying greater automation. Such systems can perform a whole host of activities that are usually completed manually: they can automatically keep track of stock levels, produce certifi cates of analysis, block processes if the correct approvals have not been attained, alert to instruments requiring maintenance, and much more. By tracking stock and alerting when levels are low, automated workfl ows enable supplies to be ordered as needed, while also decrementing and adjusting inventory records to refl ect up-to-date usage – without the need for manual input.


Automation not only improves process effi ciencies, but also frees up laboratory technicians so they can focus on valuable research rather than needing to manually gather, log and manage data. Auto-captured data is subsequently standardised and centralised by automated informatics systems, and stored in a single central database with a clear chain of custody. By storing data centrally, rather than in numerous individual silos, integrated solutions connect and collate various data sources in one repository. This enables a better understanding of wider-scale trends - from tracking seasonal production patterns to estimating likely resource requirements - and, therefore, helps organisations make fast, well informed decisions.


However, complete system integration can be a challenge to achieve without the right planning and support. Any such project is likely to require input from various stakeholders across the organisation to ensure all considerations are taken into account and also to secure buy-in and approval. Since many people and operations will be affected by system updates, there is a need for well-planned change management. Sites may have multiple different legacy systems, potentially making transition an even more complex endeavour if undertaken without support. To bridge the gaps between different facilities and informatics systems, an integrated platform must be able to bring together numerous existing data sources on to a single compliant solution.


Considering these and other challenges, it is essential that pharmaceutical developers and manufacturers are provided with the right solution to meet their needs - and that they select a partner that can offer suitable direction and support.


Accelerating pharmaceutical pipelines


with integration In any organisation, the presence and prevalence of a ‘silo mentality’ is damaging to productivity and can stymie innovation. Pharmaceutical organisations often comprise multiple departments and locations, all of which require data to be accurately captured, stored, updated and shared as needed. To increase operational effi ciency and unlock new opportunities for optimisation, facilities can benefi t by shifting away from disconnected systems and data sources towards a single, integrated system that allows for greater automation of manual processes. Here, fully integrated laboratory software suites offer a streamlined solution. Systems such as Thermo Scientifi c SampleManager LIMS software are comprised of LIMS, laboratory execution system (LES), scientifi c data management system (SDMS) and electronic lab notebook (ELN) capabilities. The complete solution helps to manage laboratory processes and procedures, connects different laboratories and sites together to manage samples, resources, instruments, equipment, stocks and suppliers, drives quality and process integrity through repeatable procedures - and captures and manages the data generated so it can be used to its full potential.


Whether an organisation is comprised of a single smaller laboratory or a global multi-site network of laboratories and manufacturing plants, a complete laboratory software solution offers essential benefits as a result of increased connectivity, such as gains in productivity and efficiency. As data is archived in a central repository and can be retrieved and visualised on demand, staff can easily track the progress of a given sample from receipt to report delivery regardless of when in their data retention period the sample was acquired. Data accessibility is a key benefit. Rather than needing to chase data from across different manufacturing and development stages or from multiple facilities, decision-makers can instead access and use it on demand to reach swifter and more informed conclusions.


Standard Operating Procedures (SOPs) can also be managed through the LES and operators are guided step by step through the process execution, increasing accuracy and reducing process nonconformance. Within a distributed network, LIMS enable best practices to be shared between laboratories at different locations, creating greater opportunities for organisation-wide optimisation. Other systems in use at any laboratory site can be easily integrated with an advanced LIMS, from Chromatography Data Systems (CDS) to Enterprise Resource Planning (ERP) and Manufacturing Execution Systems (MES). Overall, this increased connectivity enables staff to improve efficiency and data integrity, spend less time on manual data management and maximise their productivity.


As all data is stored and accessible in a single central repository, LIMS provide organisations with the potential to implement innovative data analytics strategies including artificial intelligence (AI) like machine learning (ML), which can help identify trends and patterns, optimise processes for the future and more. High-quality, well-structured data stored in a ‘data lake’ rather than disparate silos is the foundation for all AI technologies; such innovation is becoming increasingly prevalent as more pharmaceutical organisations look to implement Pharma 4.0 and is, therefore, an important part of staying competitive in an advanced and forward-thinking industry.


Alongside integration, optimisation and innovation, a core element of any information management system is compliance. Pharmaceutical manufacturing laboratories must comply with a range of essential regulation and guidance, including ISO 17025, GLP and cGMP. Integrated LIMS bring a ‘single system of truth’: information is only logged once in a largely automated way, and is then fully traceable, protecting data integrity and improving accuracy (as there are fewer chances for errors and data is traceable throughout the process).


With an integrated laboratory solution, regulatory compliance is streamlined, data review and visualisation are faster, and samples that are trending out of specification are identified before a sample fails. It also provides access to comprehensive process, personnel, sample, product and system information. LIMS prevent a user from executing work when they require training or when an instrument requires calibration, ensuring compliance and minimising rework. This further accelerates the process of drug production, helping to maximise profit and productivity.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76